Article History
Accepted: 28 February 2022
First Online: 3 June 2022
Declarations
:
: Tarek Khedro has no conflicts of interest. Jason M. Duran JMD is a paid consultant for Lexeo Therapeutics (New York, NY). He also reports US Non-Provisional Application No. 14/900,809. Eric D. Adler reports consulting for Abiomed, Novartis, Abbott, Ionis Pharmaceuticals, Sana Biotechnology, Medtronic, Lexeo Pharmaceuticals, Cytokinetics, and Endotronics. He also reports Papillion Therapeutics (Founder and Board Member) and ResQ Pharmaceuticals (Scientific Advisory Board); he is a Shareholder for Rocket Pharmaceuticals; and he was an expert witness for AstraZeneca.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.